A vs COR: fair value comparison
Agilent Technologies, Inc. and Cencora, Inc. · Updated 2026-10-19
Both currently screen as fairly valued on TickrTrends' Forward Fair Value model. Within Healthcare, COR currently sits closer to the top of our ranking by discount to fair value. A carries the stronger quality grade.
| A | COR | |
|---|---|---|
| Verdict | Fairly valued | Fairly valued |
| Last price | $170.54 | $323.85 |
| 12-month range | $110.24–$175.55 | $252.74–$374.75 |
| Rank by discount to fair value | #62 of 108 Healthcare | #58 of 108 Healthcare |
| Quality grade | B | F |
| Leverage | Moderate | High |
| Margin trend | Stable | Stable |
| Revenue growth | Modest | Modest |
| RSI zone | Neutral | Overbought |
| DCF cross-check | — | Overvalued |
| 52-week position | The top quarter | The upper-middle quarter |
Full single-stock breakdowns: A fair value analysis · COR fair value analysis